1. Home
  2. ZVIA vs ONCY Comparison

ZVIA vs ONCY Comparison

Compare ZVIA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

N/A

Current Price

$1.38

Market Cap

126.3M

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

N/A

Current Price

$0.85

Market Cap

109.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZVIA
ONCY
Founded
2007
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Pharmaceuticals and Biotechnology
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
109.1M
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
ZVIA
ONCY
Price
$1.38
$0.85
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.93
$7.33
AVG Volume (30 Days)
407.7K
644.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
55.88
N/A
EPS
N/A
N/A
Revenue
$161,259,000.00
N/A
Revenue This Year
$8.30
N/A
Revenue Next Year
$6.87
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
4.01
N/A
52 Week Low
$1.11
$0.73
52 Week High
$2.81
$1.51

Technical Indicators

Market Signals
Indicator
ZVIA
ONCY
Relative Strength Index (RSI) 43.37 53.15
Support Level $1.27 $0.85
Resistance Level $1.53 $0.87
Average True Range (ATR) 0.06 0.04
MACD 0.01 0.00
Stochastic Oscillator 46.73 56.29

Price Performance

Historical Comparison
ZVIA
ONCY

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: